Ceribell EEG

Ceribell, Inc., the developer of the first AI-powered point-of-care EEG diagnostic system, is revolutionizing seizure management in acute care.

Ceribell’s mission is to make EEG diagnostics widely available, more efficient, and more cost-effective, to improve the detection and treatment of neurological conditions. The Ceribell system provides rapid access to accurate diagnostic information and continuous monitoring at the bedside 24/7, enabling precise patient care and hospital-wide efficiencies. The Ceribell system first received FDA 510

(k) clearance in 2017 and is commercially available in the United States. The latest ClarityPro™ AI algorithm is the first and only FDA-indicated software for the diagnosis of Electrographic Status Epilepticus with U.S. Centers for Medicare and Medicaid Services approved New Technology Add-on Payment (NTAP).

06/11/2026

New study reinforces the association between Ceribell’s Clarity® AI algorithm seizure burden measurements and neurological outcomes.

A new study published in Critical Care Medicine highlights that the "seizure burden" measured by Ceribell’s Clarity® artificial intelligence (AI) algorithm is associated with a patient's increased odds of disability.

Why this matters:
In a retrospective analysis of data from 359 patients at leading institutions like Massachusetts General Hospital and Yale, researchers found that higher seizure burden is linked to significantly higher odds of disability. Specifically, every hour of seizure activity recorded was associated with nearly double the risk of a poor outcome.

By providing real-time, actionable insights, Ceribell empowers medical teams in the ICU and Emergency Department to act faster, potentially altering the trajectory of a patient’s recovery.

Learn more: https://doi.org/10.1097/CCM.0000000000007158

06/09/2026

We’re heading to , and we're bringing our newest innovation in bedside brain monitoring. 🧠 Continuous, objective delirium monitoring is about to change critical care, and we can't wait to share an exclusive first look!

Visit the Ceribell exhibit and find out how we're transforming bedside delirium assessment.

Can't make it to the show? Request a virtual walkthrough here: https://ceribell.com/ads-2026/

06/08/2026

Celebrating Ceribell Citizens' Award winner Christina Olivo, Executive Assistant! Christina drives operations with incredible empathy, moving our mission forward with warmth and an impact-driven mindset. Ceribell is lucky to have her on our team!

06/05/2026

Congrats to Ceribell Citizens' Award winner Francois Decuir, Solutions Engineer! Francois consistently prioritizes high-impact opportunities that deliver meaningful outcomes for patients, while aligning teams around key priorities and reinforcing a culture of accountability and purpose.

06/03/2026

Huge congratulations to CEO Impact Award winner Michael Cellini, Regional Director! Mike is incredibly impact-driven, fostering strong alignment across customer-facing departments. He also serves as a thought leader on Ceribell healthcare system strategy while actively mentoring his peers.

06/01/2026

Alarming—but often unseen.

Multiple pediatric patient populations are at risk for non-convulsive status epilepticus ( ), a condition that can only be detected with . Ceribell Point-of-Care EEG delivers results in minutes using an AI-powered seizure detection algorithm—cleared for patients. Learn more: https://ceribell.com/for-providers/pediatrics/

05/29/2026

are the most common neurological emergency in , and 1 hour in seizure is associated with later language and neurocognitive impairment.* Yet diagnostic challenges related to non-convulsive seizures ( ) can lead to under- and over-treatment. Ceribell provides 24/7 continuous monitoring for neonatal brain care. Learn more: https://ceribell.com/neonate/

05/27/2026

From Evidence to Impact: How Ceribell is Transforming Point-of-Care EEG with AI
Experts share how faster, smarter EEG supports earlier detection, simpler workflows, and better patient outcomes.
Watch the full session here: https://ceribell.com/ncs-video/

05/25/2026

Clinical exam isn’t enough. EEG is the ONLY way to detect non-convulsive status epilepticus. Dr. Foreman discusses when, why, and how to use it faster, before critical changes become irreversible in high-acuity patients.
Watch now: https://ceribell.com/sccm25-webcast

05/22/2026

Thanks to the organizers and all the who visited us and learned about the latest innovations from Ceribell. Missed us? You can still see what all the excitement is about. Request a demo! https://ceribell.com/demo/

Address

360 N Pastoria Avenue
Sunnyvale, CA
94085

Telephone

+18004360826

Website

http://Ceribell.com/

Alerts

Be the first to know and let us send you an email when Ceribell EEG posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Ceribell EEG:

Shortcuts

Want your practice to be the top-listed Clinic in Sunnyvale?